<code id='001063285A'></code><style id='001063285A'></style>
    • <acronym id='001063285A'></acronym>
      <center id='001063285A'><center id='001063285A'><tfoot id='001063285A'></tfoot></center><abbr id='001063285A'><dir id='001063285A'><tfoot id='001063285A'></tfoot><noframes id='001063285A'>

    • <optgroup id='001063285A'><strike id='001063285A'><sup id='001063285A'></sup></strike><code id='001063285A'></code></optgroup>
        1. <b id='001063285A'><label id='001063285A'><select id='001063285A'><dt id='001063285A'><span id='001063285A'></span></dt></select></label></b><u id='001063285A'></u>
          <i id='001063285A'><strike id='001063285A'><tt id='001063285A'><pre id='001063285A'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:612

          De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

          He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

          advertisement

          On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

          “I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

          We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

          advertisement

          Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

          Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

          LETTER TO THE EDITOR

          Have an opinion on this essay? Submit a letter to the editor here.

          knowledge

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Surge in Apellis stock fueled by confidence in safety of its eye drug
          Surge in Apellis stock fueled by confidence in safety of its eye drug

          MollyFerguson/STATSharesofApellisPharmaceuticalsarerebounding,drivenbyagrowingbeliefamongsomeinvesto

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Roche acquires Telavant from Roivant, adding experimental IBD treatment

          SebastienBozon/AFPviaGettyImagesRochesaidMondayitwasbuyingTelavantHoldingsfor$7.1billionupfront,pick